Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5858)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2022 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ueno M, Takeda H, Takai A, Seno H. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives. World J Gastroenterol 2022; 28(27): 3410-3421 [PMID: 36158261 DOI: 10.3748/wjg.v28.i27.3410] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i27/3410.htm |
| Number | Citing Articles |
| 1 |
Han Li, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Xiao Zhang, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li. Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis. Expert Review of Gastroenterology & Hepatology 2023; 17(11): 1159 doi: 10.1080/17474124.2023.2279175
|
| 2 |
Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Maria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD. Current Obesity Reports 2024; 13(3): 510 doi: 10.1007/s13679-024-00574-z
|
| 3 |
Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Katarina Malinowsky, Peter Findeisen, Johannes Kolja Hegel, Wenzel Schöning, Kairat Madin, Konstantin Kroeniger, Henry Lik-Yuen Chan, Ashish Sharma. Comparative Evaluation of Multimarker Algorithms for Early-Stage HCC Detection in Multicenter Prospective Studies. JHEP Reports 2024; : 101263 doi: 10.1016/j.jhepr.2024.101263
|
| 4 |
Kaleb Tesfai, Jordan Pace, Nora El-Newihi, Maria Elena Martinez, Monica Tincopa, Rohit Loomba. Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2024; doi: 10.1016/j.cgh.2024.06.038
|
| 5 |
Rana A. Youness, Hossam A. Hassan, Tasneem Abaza, Ahmed A. Hady, Hekmat M. El Magdoub, Mohamed Ali, Johannes Vogel, Markus Thiersch, Max Gassmann, Nadia M. Hamdy, Mostafa A. Aboouf. A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine. Cells 2024; 13(15): 1245 doi: 10.3390/cells13151245
|
| 6 |
Masayuki Ueno, Takahisa Kayahara, Hiroyuki Takabatake, Youichi Morimoto, Motowo Mizuno. Clinical characteristics and diagnostic process of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Kanzo 2023; 64(3): 122 doi: 10.2957/kanzo.64.122
|
| 7 |
Marina Montagnani Marelli, Chiara Macchi, Massimiliano Ruscica, Patrizia Sartori, Roberta Manuela Moretti. Anticancer Activity of Delta-Tocotrienol in Human Hepatocarcinoma: Involvement of Autophagy Induction. Cancers 2024; 16(15): 2654 doi: 10.3390/cancers16152654
|
| 8 |
Marlene Sophia Kohlhepp, Hanyang Liu, Frank Tacke, Adrien Guillot. The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1129831
|
| 9 |
Madalina-Gabriela Taru, Monica Lupsor-Platon. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography. Cancers 2023; 15(16): 4097 doi: 10.3390/cancers15164097
|
| 10 |
Zhao Li, Lan Lan, Yujia Zhou, Ruoxing Li, Kenneth D. Chavin, Hua Xu, Liang Li, David J.H. Shih, W. Jim Zheng. Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health records. Journal of Biomedical Informatics 2024; 152: 104626 doi: 10.1016/j.jbi.2024.104626
|
| 11 |
Kainan Zhang, Mengsi Yu, Hui Liu, Zhao Hui, Ning Yang, Xiaojuan Bi, Li Sun, RenYong Lin, Guodong Lü. Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma. PeerJ 2022; 10: e14415 doi: 10.7717/peerj.14415
|
| 12 |
Carmelo Laface, Girolamo Ranieri, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Michele Ammendola, Marigia Laterza, Gerardo Cazzato, Riccardo Memeo, Giovanni Mastrandrea, Marco Lioce, Palma Fedele. Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma. Cancers 2023; 15(3): 654 doi: 10.3390/cancers15030654
|